Clinical Trials on Hereditary Hemorrhagic Telangiectasia in Australia
Total 718 results
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Johns Hopkins UniversityMayo Clinic; Medical University of Graz; Radboud University Medical Center; University... and other collaboratorsRecruitingRetinitis PigmentosaUnited States, Austria, Mexico, Netherlands, United Kingdom, Germany, Canada, Switzerland
-
TeneoOne Inc.RecruitingRelapsed/Refractory Multiple MyelomaAustralia, Germany, Japan, Spain, United States, Italy, Poland
-
SanofiRecruitingPlasma Cell Myeloma RefractoryFrance, Australia, Greece, Italy, Norway, United States, Portugal, Puerto Rico
-
Genzyme, a Sanofi CompanyActive, not recruitingHemophiliaChina, Hungary, Turkey, Canada, Korea, Republic of, United States, Australia, Denmark, France, Germany, India, Ireland, Israel, Italy, Japan, Malaysia, South Africa, Taiwan, Ukraine, United Kingdom
-
Merck Sharp & Dohme LLCActive, not recruitingDengue Virus | Dengue DiseaseUnited States, Australia, Canada, Finland, Germany, Israel, Taiwan
-
CSL BehringCompletedHemophilia BSpain, Italy, France, Germany, Austria, Israel
-
BeiGeneRecruitingRelapsed/Refractory Multiple MyelomaUnited States, China, Australia, Korea, Republic of, Canada, United Kingdom, New Zealand, Brazil
-
The University of Texas Health Science Center,...Baxter Healthcare Corporation; Rho, Inc.CompletedHemophilia AUnited States, Austria, Italy, Netherlands, Sweden
-
Novartis PharmaceuticalsCompletedBone Marrow Diseases | Hematologic Diseases | Blood Coagulation Disorders | Hemorrhagic Disorders | Primary Myelofibrosis | Myeloproliferative Disorders | Polycythemia Vera | Thrombocytosis | Essential Thrombocythemia | Blood Platelet DisordersUnited Kingdom, Belgium, Canada, France, Australia, Netherlands, Spain, Denmark, Ireland, Italy, Germany
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaUnited States, Belgium, United Kingdom, Netherlands, France, Australia
-
Genentech, Inc.Hoffmann-La RocheRecruitingMultiple MyelomaKorea, Republic of, United States, Denmark, Italy, Spain, France, Japan, Israel, United Kingdom, Poland, Australia, Canada, Czechia
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, Belgium, United Kingdom, France, Australia
-
OctapharmaRecruitingAcute Major BleedingUnited States, Spain, Bosnia and Herzegovina, Croatia, Georgia, Italy, Poland, Germany, Turkey, United Kingdom, Ukraine, France, Austria
-
GlaxoSmithKlineRecruitingMultiple MyelomaUnited States, Australia, Italy, Japan, Poland, Spain, United Kingdom, France, Germany, Greece, Canada, China, Israel, Korea, Republic of, Brazil, Russian Federation, Czechia, New Zealand, Turkey
-
Baxalta now part of ShireBaxter Innovations GmbHTerminatedHemophilia APoland, United States, Bulgaria, Serbia, Canada, Russian Federation, Germany, Netherlands, Lithuania, Czechia, Austria, Spain
-
CSL BehringCompletedHemophilia A | Severe Hemophilia AUnited States, Australia, Austria, Canada, Czechia, France, Georgia, Germany, Hungary, Ireland, Italy, Japan, Lebanon, Malaysia, Netherlands, Philippines, Poland, Portugal, Romania, South Africa, Spain, Switzerland, Thailand, Ukraine, United...
-
Novartis PharmaceuticalsCompletedCryopyrin-associated Periodic Syndromes (CAPS) | Familial Cold Autoinflam Syn (FCAS) | Muckle-wells Syn (MWS) | Neonatal Onset Multisystem Inflam Disease (NOMID)Switzerland, United States, Germany, Norway, Austria
-
Alnylam PharmaceuticalsCompletedAcute Hepatic PorphyriaUnited States, Belgium, Bulgaria, France, Italy, Mexico, Spain, Taiwan, United Kingdom, Netherlands, Korea, Republic of, Switzerland, Czechia, Poland, Finland, Australia, Germany, Israel, Norway, South Africa
-
Freeline TherapeuticsCompletedHemophilia B | Blood Coagulation Disorders, Inherited | Blood Coagulation Disorder | Haematologic DiseaseUnited States, United Kingdom, Australia, Netherlands, Austria, France, Ireland, Italy, Turkey, Canada, Germany, South Africa
-
Dermatology Specialties Limited PartnershipCompletedTuberous Sclerosis | Facial AngiofibromaUnited States, Taiwan, Serbia, Spain, Australia, Czechia, Hungary, New Zealand, Slovakia
-
Hoffmann-La RocheCompletedHemophilia ACanada, Australia, Belgium, India, Germany, Israel, Italy, Spain, Colombia, United Kingdom, Netherlands, Saudi Arabia, Hungary, Guatemala, Russian Federation, Poland, Switzerland, Finland, Panama, Brazil, Mexico, Portugal, Romania, Sw...
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaUnited States, Australia, Spain, Bulgaria, Poland, Belgium, France, Germany, Italy, Hungary, United Kingdom, Greece, Russian Federation, Brazil, China, Korea, Republic of, Japan, Canada, Netherlands
-
Swedish Orphan BiovitrumICON plcCompletedHemophilia AFrance, Italy, Norway, Sweden, United Kingdom, Austria, Belgium, Finland, Spain
-
Viridian Therapeutics, Inc.Active, not recruitingThyroid Eye DiseaseUnited States, Spain, United Kingdom, Canada, Germany, Italy, Netherlands, Australia, France, Turkey
-
European Society for Blood and Marrow TransplantationCompletedMultiple MyelomaAustria, Denmark, Germany, Finland, Canada, Sweden, Norway, France, Italy, United Kingdom, Turkey
-
GWT-TUD GmbHHannover Medical School; Hoffmann-La RocheCompleted
-
AbbVieRecruitingRelapsed/Refractory Multiple MyelomaUnited States, Australia, Israel, United Kingdom
-
University of Alabama at BirminghamMedtronic; The Children's Tumor FoundationTerminatedNF1 | Congenital Pseudarthrosis of TibiaUnited States, Australia
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationActive, not recruitingPrimary Myelofibrosis | Myelofibrosis | Post-Polycythemia VeraAustralia, Austria, Belgium, China, Czechia, France, Germany, Hungary, Italy, Korea, Republic of, Netherlands, Poland, Russian Federation, Spain, Ireland, United Kingdom
-
Hoffmann-La RocheRecruitingMultiple MyelomaUnited States, Italy, Spain, Australia, Belgium, Israel, Germany, France
-
AmgenCompletedEnd-stage Renal Disease | Relapsed Multiple MyelomaUnited States, Australia, Canada
-
Stichting European Myeloma NetworkJanssen PharmaceuticaRecruitingMultiple MyelomaAustria, Greece, Italy, Netherlands, Germany
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaUnited States, Korea, Republic of, Canada, Israel, Spain, Japan, Australia
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, Australia, France, Spain, Israel, India, Romania, Korea, Republic of, Singapore, Russian Federation, Poland
-
Janssen-Cilag International NVCompletedMultiple MyelomaTurkey, Greece, Czech Republic, Austria, Germany, Sweden, United Kingdom, Denmark
-
PfizerActive, not recruitingHemophilia ASpain, Taiwan, Australia, United States, Japan, France, Turkey, Germany, Korea, Republic of, United Kingdom, Saudi Arabia, Canada, Greece, Sweden, Brazil, Italy
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AAustria, Spain, United States, Germany, Serbia, Taiwan, Bulgaria
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireCompletedAcquired Hemophilia AUnited States, Italy, United Kingdom, Germany, Austria, Netherlands, France
-
CelgeneCompletedMultiple MyelomaUnited States, Spain, Austria, Greece, Netherlands, Sweden
-
Novo Nordisk A/SEnrolling by invitationHaemophilia AAustria, Spain, Bulgaria, Croatia, Estonia, Hungary, Italy, Lithuania, Portugal, Greece, Germany, Czechia, Slovenia, Switzerland, Slovakia
-
Novartis PharmaceuticalsCompletedCancerFrance, Australia, United States, Canada, United Kingdom
-
PharmaMarCompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Austria, Belgium, Czechia, France, Germany, Greece, Ireland, Italy, Korea, Republic of, Netherlands, New Zealand, Poland, Portugal, Puerto Rico, Spain, Taiwan, United Kingdom
-
University of IowaJohns Hopkins University; University of Colorado, Denver; King's College Hospital... and other collaboratorsRecruitingCharcot-Marie-Tooth Disease, Type Ia (Disorder) | HMSNUnited States, Italy, United Kingdom, Australia
-
Novo Nordisk A/SActive, not recruitingHaemophilia A With Inhibitors | Haemophilia B With InhibitorsSpain, Korea, Republic of, India, Australia, United Kingdom, Russian Federation, Poland, Ukraine, Thailand, Mexico, United States, Turkey, Japan, South Africa, Serbia, France, Croatia, Denmark, Algeria, Bulgaria, Malaysia, Portugal, Slovaki... and more
-
Bioverativ, a Sanofi companyActive, not recruitingHemophilia AUnited States, Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, France, Germany, Greece, Hungary, Ireland, Italy, Japan, Korea, Republic of, Netherlands, Spain, Sweden, Switzerland, Taiwan, Turkey, United Kingdom
-
SFJ Pharmaceuticals, Inc.RecruitingHemorrhage | Invasive Procedure | Urgent SurgeryUnited States, Netherlands, China, Sweden, Austria, Belgium, France, Italy, Spain, Switzerland, United Kingdom, Canada, Germany
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaUnited States, Spain, France, Germany, Australia, United Kingdom, Canada, Italy
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedChronic Lymphocytic Leukaemia (CLL) | Multiple Myeloma (MM) | B-Cell Non-Hodgkin Lymphoma (NHL)France, Australia, Germany, Korea, Republic of, United Kingdom, Hungary, Poland, Singapore
-
GlaxoSmithKlineRecruitingMultiple MyelomaAustralia, Germany, Italy, Spain, United States, Korea, Republic of, Canada, France, Poland, United Kingdom